Home > Qtrly Results > AJANTA PHARMA

AJANTA PHARMA
Quarterly Results Analysis [Mar2024]

AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Quarterly Results

Consolidated Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
Audited
Jun2022
UnAudited
Revenues ₹1,054 Cr ₹1,105 Cr ₹1,028 Cr ₹1,021 Cr ₹882 Cr ₹972 Cr ₹938 Cr ₹951 Cr
Expenses ₹776 Cr ₹791 Cr ₹738 Cr ₹750 Cr ₹732 Cr ₹802 Cr ₹742 Cr ₹729 Cr
Operating Income ₹278 Cr ₹314 Cr ₹291 Cr ₹271 Cr ₹149 Cr ₹170 Cr ₹196 Cr ₹222 Cr
Other Income ₹36 Cr ₹14 Cr ₹21 Cr ₹32 Cr ₹37 Cr ₹35 Cr ₹40 Cr ₹33 Cr
Interest ₹2 Cr ₹2 Cr ₹2 Cr ₹1 Cr ₹1 Cr ₹3 Cr ₹1 Cr ₹1 Cr
Depreciation ₹34 Cr ₹34 Cr ₹34 Cr ₹33 Cr ₹33 Cr ₹33 Cr ₹33 Cr ₹32 Cr
Profit Before Tax ₹278 Cr ₹291 Cr ₹276 Cr ₹269 Cr ₹152 Cr ₹168 Cr ₹203 Cr ₹222 Cr
Profit After Tax ₹203 Cr ₹210 Cr ₹195 Cr ₹208 Cr ₹122 Cr ₹135 Cr ₹157 Cr ₹175 Cr
EPS ₹16.04 ₹16.62 ₹15.46 ₹16.47 ₹9.68 ₹10.46 ₹12.18 ₹13.58
Industry Peers & Returns1W1M1Y
AJANTA PHARMA 1.1% 13.6% 82.6%
SUN PHARMACEUTICAL INDUSTRIES -2.9% 0% 59.6%
CIPLA 5.8% 6.2% 60.9%
DR REDDYS LABORATORIES 0.9% -1.5% 32.2%
ZYDUS LIFESCIENCES -2.6% 15.3% 114.4%
DIVIS LABORATORIES 5% 8% 25.9%
MANKIND PHARMA -2.3% -14% 57.7%
TORRENT PHARMACEUTICALS -3.4% -2.7% 61.2%
LUPIN -2.8% 2.1% 110.5%

AJANTA PHARMA Quarterly Revenues

Revenues
Q-o-Q

-4.62 %

Y-o-Y

19.53 %

Quarters Revenues % Change
Mar2024 ₹1,054 Cr
-4.62
Dec2023 ₹1,105 Cr
7.46
Sep2023 ₹1,028 Cr
0.72
Jun2023 ₹1,021 Cr
15.79
Mar2023 ₹882 Cr
-9.25
Dec2022 ₹972 Cr
3.59
Sep2022 ₹938 Cr
-1.35
Jun2022 ₹951 Cr -

AJANTA PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-11.38 %

Y-o-Y

86.33 %

Quarters Operating Profit % Change
Mar2024 ₹278 Cr
-11.38
Dec2023 ₹314 Cr
8.05
Sep2023 ₹291 Cr
7.13
Jun2023 ₹271 Cr
81.64
Mar2023 ₹149 Cr
-11.90
Dec2022 ₹170 Cr
-13.64
Sep2022 ₹196 Cr
-11.46
Jun2022 ₹222 Cr -
Operating Margins
Q-o-Q

-7.11 %

Y-o-Y

55.84 %

Quarters Operating Margin% % Change
Mar2024 26.4%
-7.11
Dec2023 28.42%
0.57
Sep2023 28.26%
6.36
Jun2023 26.57%
56.85
Mar2023 16.94%
-2.92
Dec2022 17.45%
-16.63
Sep2022 20.93%
-10.25
Jun2022 23.32% -

AJANTA PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-3.48 %

Y-o-Y

65.82 %

Quarters Profit After Tax % Change
Mar2024 ₹203 Cr
-3.48
Dec2023 ₹210 Cr
7.54
Sep2023 ₹195 Cr
-6.16
Jun2023 ₹208 Cr
70.24
Mar2023 ₹122 Cr
-9.11
Dec2022 ₹135 Cr
-14.11
Sep2022 ₹157 Cr
-10.32
Jun2022 ₹175 Cr -
PAT Margins
Q-o-Q

1.21 %

Y-o-Y

38.74 %

Quarters PAT Margin(%) % Change
Mar2024 19.23 %
1.21
Dec2023 19 %
0.05
Sep2023 18.99 %
-6.82
Jun2023 20.38 %
47.04
Mar2023 13.86 %
0.14
Dec2022 13.84 %
-17.08
Sep2022 16.69 %
-9.10
Jun2022 18.36 % -

AJANTA PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-3.49 %

Y-o-Y

65.70 %

Quarters EPS % Change
Mar2024 ₹16.04
-3.49
Dec2023 ₹16.62
7.50
Sep2023 ₹15.46
-6.13
Jun2023 ₹16.47
70.14
Mar2023 ₹9.68
-7.46
Dec2022 ₹10.46
-14.12
Sep2022 ₹12.18
-10.31
Jun2022 ₹13.58 -

You may also like the below Video Courses